The Journal of Experimental Medicine · 1987 · 90 citations · 17 references
Life SciencesBiochemistryGlycobiologyInflammationInnate ImmunityCytokine BiologyGlycosylation PathwaysInflammatory Cell ResponsesInflammatory Response RegulationInflammatory SignalingAcute-phase MediatorsAcute-phase ProteinsGlycosylation AnalysisGlycosylation In DiseaseInflammatory Liver Injury
The acute-phase response to inflammatory stimuli, characterized by increased synthesis of acute-phase proteins (APP), is often accompanied by changes in the glycosylation patterns of some of these proteins. While expression of APP genes in hepatocytes is regulated by monokines, mechanisms governing changes in glycosylation are not known. Exposure of human hepatoma cell line Hep 3B to conditioned medium from LPS-activated human monocytes and to medium from the keratocarcinoma cell line COLO-16 led to increased synthesis of alpha 1 proteinase-inhibitor and ceruloplasmin and to alterations of their glycosylation patterns similar to those seen in human serum in various inflammatory states. IL-1, tumor necrosis factor, and hepatocyte stimulating factor I increased synthesis of ceruloplasmin without alterations in the pattern of its glycosylation. These findings demonstrate that altered glycosylation seen in plasma in some inflammatory states can be explained by the effects of monokines on glycosylation in hepatocytes and that gene expression and glycosylation of some APP during the acute-phase response may be regulated by different mechanisms.
17
C.‐B. Laurell · Scandinavian Journal of Clinical and Laboratory Investigation · 1972 · 1.7K citations
G.J. Darlington, Debra Rose Wilson, Lawrence B. Lachman · The Journal of Cell Biology · 1986 · 400 citations · Full text
Acute phase proteins as disease markers.
Irving Kushner, A Mackiewicz · PubMed · 1987 · 204 citations